ArticleScientific reports2024

Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy.

Jian Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.